These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2120167)

  • 1. Formation of dihydroxy derivative of ML-236B from ML-236B (compactin) by lipid peroxidation.
    Serizawa N; Nakahara K; Matsuoka T
    J Antibiot (Tokyo); 1990 Aug; 43(8):1031-3. PubMed ID: 2120167
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipid lowering drugs.
    Bocanegra TS; Tobert JA
    BMJ; 1990 May; 300(6733):1195. PubMed ID: 2112035
    [No Abstract]   [Full Text] [Related]  

  • 3. Purification and characterization of cytochrome P-450sca from Streptomyces carbophilus. ML-236B (compactin) induces a cytochrome P-450sca in Streptomyces carbophilus that hydroxylates ML-236B to pravastatin sodium (CS-514), a tissue-selective inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme-A reductase.
    Matsuoka T; Miyakoshi S; Tanzawa K; Nakahara K; Hosobuchi M; Serizawa N
    Eur J Biochem; 1989 Oct; 184(3):707-13. PubMed ID: 2509201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3 alpha-Hydroxy-ML-236B (3 alpha-hydroxycompactin), microbial transformation product of ML-236B (compactin).
    Serizawa N; Nakagawa K; Tsujita Y; Terahara A; Kuwano H
    J Antibiot (Tokyo); 1983 May; 36(5):608-10. PubMed ID: 6874578
    [No Abstract]   [Full Text] [Related]  

  • 5. Microbial phosphorylation of compactin (ML-236B) and related compounds.
    Endo A; Yamashita H; Naoki H; Iwashita T; Mizukawa Y
    J Antibiot (Tokyo); 1985 Mar; 38(3):328-32. PubMed ID: 4008328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbial hydroxylation of ML-236B (compactin) and monacolin K (MB-530B).
    Serizawa N; Nakagawa K; Hamano K; Tsujita Y; Terahara A; Kuwano H
    J Antibiot (Tokyo); 1983 May; 36(5):604-7. PubMed ID: 6874577
    [No Abstract]   [Full Text] [Related]  

  • 7. Microbial hydroxylation of compactin (ML-236B) and monacolin K.
    Yamashita H; Tsubokawa S; Endo A
    J Antibiot (Tokyo); 1985 May; 38(5):605-9. PubMed ID: 4040510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue-selective inhibition of cholesterol synthesis in vivo by pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.
    Koga T; Shimada Y; Kuroda M; Tsujita Y; Hasegawa K; Yamazaki M
    Biochim Biophys Acta; 1990 Jul; 1045(2):115-20. PubMed ID: 2116173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taxonomy of actinomycetes capable of hydroxylation of ML-236B (compactin).
    Okazaki T; Serizawa N; Enokita R; Torikata A; Terahara A
    J Antibiot (Tokyo); 1983 Sep; 36(9):1176-83. PubMed ID: 6630076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbial conversion of compactin (ML-236B) to ML-236A.
    Komagata D; Yamashita H; Endo A
    J Antibiot (Tokyo); 1986 Nov; 39(11):1574-7. PubMed ID: 3793626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A two component-type cytochrome P-450 monooxygenase system in a prokaryote that catalyzes hydroxylation of ML-236B to pravastatin, a tissue-selective inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase.
    Serizawa N; Matsuoka T
    Biochim Biophys Acta; 1991 Jun; 1084(1):35-40. PubMed ID: 1905157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ML-236B (compactin) on biliary excretion of bile salts and lipids, and on bile flow, in the rat.
    Kempen HJ; De Lange J; Vos-Van Holstein MP; Van Wachem P; Havinga R; Vonk RJ
    Biochim Biophys Acta; 1984 Jul; 794(3):435-43. PubMed ID: 6743675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbial hydroxylation of ML-236B (compactin). Studies on microorganisms capable of 3 beta-hydroxylation of ML-236B.
    Serizawa N; Serizawa S; Nakagawa K; Furuya K; Okazaki T; Terahara A
    J Antibiot (Tokyo); 1983 Jul; 36(7):887-91. PubMed ID: 6684108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6 alpha-Hydroxy-iso-ML-236B (6 alpha-hydroxy-iso-compactin) and ML-236A, microbial transformation products of ML-236B.
    Serizawa N; Nakagawa K; Tsujita Y; Terahara A; Kuwano H; Tanaka M
    J Antibiot (Tokyo); 1983 Jul; 36(7):918-20. PubMed ID: 6549610
    [No Abstract]   [Full Text] [Related]  

  • 15. Compactin (ML-236B) and related compounds as potential cholesterol-lowering agents that inhibit HMG-CoA reductase.
    Endo A
    J Med Chem; 1985 Apr; 28(4):401-5. PubMed ID: 3981532
    [No Abstract]   [Full Text] [Related]  

  • 16. Biosynthesis of ML-236B (compactin) and monacolin K.
    Endo A; Negishi Y; Iwashita T; Mizukawa K; Hirama M
    J Antibiot (Tokyo); 1985 Mar; 38(3):444-8. PubMed ID: 4008338
    [No Abstract]   [Full Text] [Related]  

  • 17. Pravastatin and simvastatin for hypercholesterolemia.
    Med Lett Drugs Ther; 1991 Mar; 33(839):18-20. PubMed ID: 1899899
    [No Abstract]   [Full Text] [Related]  

  • 18. Hydroxylation of Compactin (ML-236B) by CYP105D7 (SAV_7469) from
    Yao Q; Ma L; Liu L; Ikeda H; Fushinobu S; Li S; Xu LH
    J Microbiol Biotechnol; 2017 May; 27(5):956-964. PubMed ID: 28274099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biosynthesis of monacolins: conversion of monacolin J to monacolin K (mevinolin).
    Kimura K; Komagata D; Murakawa S; Endo A
    J Antibiot (Tokyo); 1990 Dec; 43(12):1621-2. PubMed ID: 2276983
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of ML-236b (compactin) on sterol synthesis and low density lipoprotein receptor activities in fibroblasts of patients with homozygous familial hypercholesterolemia.
    Haba T; Mabuchi H; Yoshimura A; Watanabe A; Wakasugi T; Tatami R; Ueda K; Ueda R; Kametani T; Koizumi J; Miyamoto S; Takeda R; Takeshita H
    J Clin Invest; 1981 May; 67(5):1532-40. PubMed ID: 7229037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.